In-hospital VTE full-process management system and neuromuscular stimulator based on same
Through the combination of the in-hospital VTE full-process management system and neuromuscular stimulator, the problem of lack of standards for VTE management and insufficient prevention management in the existing technology is solved, effective VTE management and risk warning are achieved, and patients' medical safety is improved.
Patent Information
- Application Number
- CN202411022752.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-12-06
AI Technical Summary
The existing technology lacks unified standards and specifications in the management of VTE in hospitals, resulting in uneven prevention and treatment effects, insufficient prevention and management of hospitalized patients, and a high risk of misdiagnosis and misdiagnosis.
A full-process management system for in-hospital VTE is designed, combining with neuromuscular stimulators, and patient information is obtained through the in-hospital HIS system interface module. The preventive measures allocation module sets the working time and number of neuromuscular stimulators according to the VTE risk level. The module detects venous thrombosis and performs early warning and stimulation. The early warning module alerts and statistics data, and the analysis module forms a summary report and uploads it to the cloud server. The neuromuscular stimulator includes an electrode sheet detection unit, a thrombus detection unit and an information transmission unit. It uses flexible B-ultrasound technology to detect the peak blood flow rate and flow rate, and automatically shut down and early warning.
The VTE management and prevention and control system of medical institutions has been standardized, effective VTE management and risk warning have been achieved, and the medical safety of patients has been improved.
Smart Images

Figure CN119075178A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the fields of information management and medical devices, and in particular to an in-hospital VTE full-process management system and a neuromuscular stimulator based on the system. Background Art
[0002] VTE is venous thromboembolism, which refers to abnormal coagulation of blood in the veins, causing complete or incomplete blockage of blood vessels. It is a venous reflux disorder. VTE has a high risk of misdiagnosis and missed diagnosis. Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE). Due to its hidden symptoms, it often leads to misdiagnosis and missed diagnosis, increasing the risk of death and disability for patients. Many medical institutions lack a standardized management system. When facing VTE prevention and treatment management, medical institutions lack unified standards and specifications, resulting in uneven prevention and treatment effects and difficulty in ensuring patient medical safety. Medical staff lack knowledge. The process management of VTE requires medical staff to have professional knowledge and skills, but currently some medical staff have limited understanding of VTE, which affects the prevention and treatment effects.
[0003] The existing in-hospital VTE process management technologies, such as the inpatient venous thromboembolism safety management system and application (CN108498076A), are combined with server, nursing control and doctor control, with the server performing risk assessment, intervention measures, calculation and judgment, and performing graded management based on different scoring values to avoid excessive treatment of patients. However, for inpatients, only risk assessment cannot meet the treatment requirements, and the prevention of venous thromboembolism is equally important. The existing technology is still insufficient in the prevention and management of inpatients. Summary of the invention
[0004] The purpose of the present invention is to address the deficiencies of the prior art and to propose an in-hospital VTE full-process management system and a neuromuscular stimulator based on the system.
[0005] The object of the present invention is achieved through the following technical solutions: a full-process management system for VTE in a hospital, which manages multiple neuromuscular stimulators, and the system includes:
[0006] The hospital HIS system interface module is used to obtain patient information;
[0007] A preventive measures allocation module, which is used to determine the working time and working frequency of the neuromuscular stimulator according to the VTE risk level assessed by the hospital, and transmit the working instructions of stimulation intensity and working time to each neuromuscular stimulator;
[0008] The neuromuscular stimulator module is used to detect whether the neuromuscular stimulator is attached to the human body and whether there is venous thrombosis. If it is not attached to the human body or there is venous thrombosis, an early warning is issued and the result is fed back to the early warning module. If there is no early warning, the work instructions of the preventive measures allocation module are implemented to perform neuromuscular stimulation and detect the peak blood flow velocity and flow during the stimulation process;
[0009] The early warning module is used to provide feedback on whether the stimulator is attached to the human body and whether there is venous thrombosis, and to remind hospital nurses to handle it;
[0010] The analysis module is used to statistically back up the relevant data after the neuromuscular stimulator works, form a summary report, and upload it to the cloud server for storage.
[0011] Furthermore, the patient information includes name, medical record number, hospitalization ward, and VTE risk level assessed by the hospital.
[0012] Furthermore, the time for the neuromuscular stimulator to start working is allocated according to the number of preventive work; the higher the VTE risk level, the more times the neuromuscular stimulator works, and the working time each time is the same.
[0013] Furthermore, the relevant data after the work includes stimulation time, stimulation frequency, and peak blood flow velocity and flow during stimulation, which assist doctors in clinical research and monitor VTE prevention effects.
[0014] In a second aspect, the present invention further provides a neuromuscular stimulator for an in-hospital VTE full-process management system, the stimulator comprising an electrode detection unit, a thrombus detection unit, an information transmission unit and a stimulation unit;
[0015] An information transmission unit is used to receive work instructions from the management system, transmit the data to the management system after the work is completed, and feed back the detection and warning results of the electrode detection unit and the thrombus detection unit to the management system;
[0016] The electrode detection unit is used to detect whether the neuromuscular stimulator is attached to the human body based on the skin surface impedance. If so, a thrombus detection is performed. If not, the stimulator alarm is triggered, the stimulation process is not recorded, and an early warning is issued;
[0017] The thrombus detection unit is used to detect whether the patient has venous thrombosis based on flexible B-ultrasound technology. If yes, the neuromuscular stimulator will not work, and the thrombus information will be fed back to the management system through the information transmission unit. If no, the stimulation unit will be started;
[0018] The stimulation unit performs neuromuscular stimulation according to the work designation received by the information transmission unit, and detects the peak blood flow velocity and flow rate during the stimulation process based on the flexible B-ultrasound technology.
[0019] Furthermore, when the stimulator is working, if it detects that it has not been attached to the human body for more than 5 minutes, the stimulator will automatically shut down and issue an alarm.
[0020] Furthermore, the flexible B-ultrasound technology is based on an array-type ultrasonic transducer to collect blood vessel images, calculate blood flow velocity and flow, and record peak values.
[0021] Furthermore, the neuromuscular stimulator is transported to the patient via a mobile device, and the mobile transfer includes a data processing center that transmits data information to the in-hospital VTE full-process management system, which has a matching touch screen for data display and control, and is used to select the neuromuscular stimulator host.
[0022] Furthermore, the mobile transposition also includes a mobile trolley column with a built-in data transmission signal line, one end of the mobile trolley column is fixed on a universal wheel mobile base, and the other end is installed with a touch screen; the mobile trolley column has a charging base for placing multiple neuromuscular stimulator hosts.
[0023] Beneficial effects of the present invention: The present invention can standardize the VTE management and prevention system of medical institutions, and realize effective management and risk warning of VTE in combination with a neuromuscular stimulator. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.
[0025] Figure 1 This is a flow chart of an in-hospital VTE full-process management system provided by the present invention.
[0026] Figure 2 It is a mobile device of the neuromuscular stimulator matched with the in-hospital VTE full-process management system in the present invention.
[0027] In the figure, 1. touch screen; 2. upper stimulator host; 3. upper charging base; 4. lower stimulator host; 5. lower charging base; 6. item storage cabinet; 7. power storage energy box; 8. universal wheel mobile base; 9. mobile trolley column; 10. upper charging connector; 11. lower charging connector; 12. data processing center. DETAILED DESCRIPTION
[0028] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described below in conjunction with the accompanying drawings and implementation examples. It should be understood that the specific implementation examples described herein are only used to explain the present invention and are not used to limit the present invention.
[0029] like Figure 1 As shown, the present invention provides an in-hospital VTE full-process management system (TPS system) for managing multiple neuromuscular stimulators, the system comprising:
[0030] The in-hospital HIS system interface module is used to obtain patient information, including name, medical record number, hospitalization ward, and VTE risk level assessed by the hospital;
[0031] The preventive measures allocation module is used to determine the working time and working frequency of the neuromuscular stimulator according to the VTE risk level, transmit the work instructions of the stimulation intensity (set according to the degree acceptable to the patient) and the working time to each neuromuscular stimulator, and reasonably allocate the time for the neuromuscular stimulator to start working according to the number of preventive work, and remind the nurse 5 minutes in advance; the higher the VTE risk level, the more times the neuromuscular stimulator works, and the working time of each time is the same; for example, for low-risk patients, prevention is performed twice a day (am8:30\pm20:30); for medium-risk patients, prevention is performed three times a day (am8:30\pm14:30\pm20:30); for high-risk patients, prevention is performed 3-4 times a day (am6:30\am11:30\pm16:30\pm21:30).
[0032] The neuromuscular stimulator module is used to detect whether the neuromuscular stimulator is attached to the human body and whether there is venous thrombosis. If it is not attached to the human body or there is venous thrombosis, an early warning will be issued and the result will be fed back to the early warning module. If there is no early warning, the work instructions of the preventive measures allocation module will be implemented, neuromuscular stimulation will be performed, and the peak blood flow velocity and flow rate during the stimulation process will be detected.
[0033] The early warning module is used to warn of feedback results such as the stimulator falling off, whether there is venous thrombosis, and whether the stimulator is attached to the human body, and remind the nurse to handle it;
[0034] The analysis module is used to statistically back up the relevant data after the neuromuscular stimulator works, form a summary report, and upload it to the cloud server for storage. The data includes stimulation time, stimulation frequency, and peak blood flow velocity and flow during stimulation; it can assist doctors in clinical research and monitor the VTE prevention effect.
[0035] The present invention also provides a neuromuscular stimulator for use in an in-hospital VTE full-process management system, comprising an electrode detection unit, a thrombus detection unit, an information transmission unit, and a stimulation unit;
[0036] The information transmission unit is used to receive the work instructions of the preventive measures allocation module, transmit the data to the analysis module after the work is completed, and feed back the detection warning results of the electrode detection unit and the thrombus detection unit to the warning module.
[0037] The electrode detection unit is used to detect whether the neuromuscular stimulator is attached to the human body based on the skin surface impedance. If it is, thrombus detection is performed. If not, the stimulator alarms, does not record the stimulation process, and issues an early warning. When the stimulator is working, if it is detected that it has not been attached to the human body for more than 5 minutes, the stimulator automatically shuts down and issues an early warning.
[0038] The thrombus detection unit is used to detect whether the patient has venous thrombosis based on flexible B-ultrasound technology. If so, the neuromuscular stimulator module will not work, and the thrombus information will be fed back to the early warning module through the information transmission unit. Otherwise, the stimulation unit will be started; the flexible B-ultrasound technology is based on an array-shaped ultrasonic transducer to collect blood vessel images, calculate blood flow velocity and flow, and record peak values. If the blood flow velocity and flow are abnormal, it can be considered that there is suspected thrombosis and further diagnosis is required.
[0039] The stimulation unit performs neuromuscular stimulation according to the work designation received by the information transmission unit, and detects the peak blood flow velocity and flow rate during the stimulation process based on the flexible B-ultrasound technology.
[0040] The above-mentioned neuromuscular stimulator is transported to the patient by a doctor or nurse through the mobile device provided by the present invention, such as Figure 2 As shown, the mobile transposition includes a touch screen 1, an upper stimulator host 2, an upper charging base 3, a lower stimulator host 4, a lower charging base 5, an item storage cabinet 6, an electric energy storage box 7, a universal wheel mobile base 8, a mobile trolley column 9, an upper charging connector 10, a lower charging connector 11 and a data processing center 12;
[0041] The data processing center 12 is connected to the in-hospital VTE full-process management system for data information transmission, and is displayed and controlled on the touch screen 1, and is used to select the neuromuscular stimulator host. A section of the mobile trolley column 9 passes through the data processing center 12 and is fixed on the universal wheel mobile base 8, and the other end is installed with a touch screen 1. The mobile trolley column 9 has a data transmission signal line, connecting the data processing center 12 and the touch screen 1. The data processing center 12 has an energy storage box 7 for power supply; the upper charging base 3, the lower charging base 5 and the item storage cabinet 6 are sequentially installed on the mobile trolley column 9, and the upper stimulator host 2 and the lower stimulator host 4 are each multiple, respectively placed on the upper charging base 3 and the lower charging base 5, and the upper charging base 3 and the lower charging base 5 are respectively provided with an upper charging connector 10 and a lower charging connector 11, which are used to connect with the data transmission signal line in the mobile trolley column 9 for charging.
[0042] The above embodiments are used to illustrate the present invention rather than to limit the present invention. Any modification and change made to the present invention within the spirit of the present invention and the protection scope of the claims shall fall within the protection scope of the present invention.
Claims
1. A full-process management system for VTE in a hospital, characterized in that: To manage multiple neuromuscular stimulators, the system includes: The hospital HIS system interface module is used to obtain patient information; A preventive measures allocation module, which is used to determine the working time and working frequency of the neuromuscular stimulator according to the VTE risk level assessed by the hospital, and transmit the working instructions of stimulation intensity and working time to each neuromuscular stimulator; The neuromuscular stimulator module is used to detect whether the neuromuscular stimulator is attached to the human body and whether there is venous thrombosis. If it is not attached to the human body or there is venous thrombosis, an early warning is issued and the result is fed back to the early warning module. If there is no early warning, the work instructions of the preventive measures allocation module are implemented to perform neuromuscular stimulation and detect the peak blood flow velocity and flow during the stimulation process; The early warning module is used to provide feedback on whether the stimulator is attached to the human body and whether there is venous thrombosis, and to remind hospital nurses to handle it; The analysis module is used to statistically back up the relevant data after the neuromuscular stimulator works, form a summary report, and upload it to the cloud server for storage.
2. According to claim 1, a hospital VTE full process management system is characterized in that: Patient information included name, medical record number, hospitalization ward, and VTE risk level assessed by the hospital.
3. The in-hospital VTE full-process management system according to claim 1 is characterized in that: The time for the neuromuscular stimulator to start working is allocated according to the number of preventive work; the higher the VTE risk level, the more times the neuromuscular stimulator works, and the working time each time is the same.
4. The in-hospital VTE full-process management system according to claim 1, characterized in that: The relevant data after the work includes stimulation time, stimulation frequency and peak blood flow velocity and flow rate during stimulation, which assist doctors in clinical research and monitor VTE prevention effects.
5. A neuromuscular stimulator for an in-hospital VTE full-process management system based on any one of claims 1-4, characterized in that: The stimulator includes an electrode sheet detection unit, a thrombus detection unit, an information transmission unit and a stimulation unit; An information transmission unit is used to receive work instructions from the management system, transmit the data to the management system after the work is completed, and feed back the detection and warning results of the electrode detection unit and the thrombus detection unit to the management system; The electrode detection unit is used to detect whether the neuromuscular stimulator is attached to the human body based on the skin surface impedance. If so, a thrombus detection is performed. If not, the stimulator alarm is triggered, the stimulation process is not recorded, and an early warning is issued; The thrombus detection unit is used to detect whether the patient has venous thrombosis based on flexible B-ultrasound technology. If yes, the neuromuscular stimulator will not work, and the thrombus information will be fed back to the management system through the information transmission unit. If no, the stimulation unit will be started; The stimulation unit performs neuromuscular stimulation according to the work designation received by the information transmission unit, and detects the peak blood flow velocity and flow rate during the stimulation process based on the flexible B-ultrasound technology.
6. The neuromuscular stimulator according to claim 5, characterized in that The flexible B-ultrasound technology is based on an array-type ultrasonic transducer to collect blood vessel images, calculate blood flow velocity and flow, and record peak values.
7. The neuromuscular stimulator according to claim 5, characterized in that The neuromuscular stimulator is transported to the patient via a mobile device. The mobile transfer includes a data processing center that transmits data information to the in-hospital VTE full-process management system. The data processing center has a matching touch screen for data display and control, and is used to select the neuromuscular stimulator host.
8. The neuromuscular stimulator according to claim 7, characterized in that The mobile transposition also includes a mobile trolley column with a built-in data transmission signal line, one end of the mobile trolley column is fixed on a universal wheel mobile base, and the other end is equipped with a touch screen; the mobile trolley column is provided with a charging base for placing multiple neuromuscular stimulator hosts.
